The effects of omega-3 fatty acids on Wnt activity in iPSC-derived neural stem cells from adult ADHD patients
Cristine M Yde Ohki, Natalie M Walter, Louisa C Dury, Letizia Del Campana, Romane Lasmarrigues, Rhiannon V McNeill, Zora Schickardt, Lukasz Smigielski, Susanne Walitza, Sarah Kittel-Schneider, Edna Grünblatt · 2026
Read The effects of omega-3 fatty acids on Wnt activity in iPSC-derived neural stem cells from adult ADHD patients by Cristine M Yde Ohki, Natalie M Walter, Louisa C Dury, Letizia Del Campana, Romane Lasmarrigues, Rhiannon V McNeill, Zora Schickardt, Lukasz Smigielski, Susanne Walitza, Sarah Kittel-Schneider, Edna Grünblatt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13185858.txt.
Introduction
Cristine Yde Ohki and co-authors test whether fish-oil fatty acids calm an overactive growth signal in brain stem cells from adults with ADHD. Their study appeared in 2026. The Wnt pathway steers brain development and upkeep, and the group's earlier work found it overactive in cells from children with the disorder. Here they grew neural stem cells from five adult patients and five healthy controls, then dosed them with the two main omega-3 fats, alone, combined, and alongside the standard stimulant drug.
Baseline pathway activity did not differ between adult patient and control cells, unlike the child findings. The team still probed how the fats and the drug moved the signal from that baseline. The authors frame omega-3 as a possible gentle add-on worth further study in adult ADHD.
Catalog record
| CREATOR | Cristine M Yde Ohki, Natalie M Walter, Louisa C Dury, Letizia Del Campana, Romane Lasmarrigues, Rhiannon V McNeill, Zora Schickardt, Lukasz Smigielski, Susanne Walitza, Sarah Kittel-Schneider, Edna Grünblatt |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The effects of omega-3 fatty acids on Wnt activity in iPSC-derived neural stem cells from adult ADHD patients Authors: Cristine M Yde Ohki, Natalie M Walter, Louisa C Dury, Letizia Del Campana, Romane Lasmarrigues, Rhiannon V McNeill, Zora Schickardt, Lukasz Smigielski, Susanne Walitza, Sarah Kittel-Schneider, Edna Grünblatt Published: 2026 ABSTRACT AbstractThe canonical Wnt signaling pathway plays a key role in neurodevelopment and in maintaining cellular homeostasis of the central nervous system in adulthood. It regulates essential processes, such as cell proliferation, differentiation, and synaptogenesis. In vivo and genetic evidence suggests an association between attention-deficit/hyperactivity disorder (ADHD) and abnormalities in the Wnt pathway. Prior research from our group indicated heightened basal Wnt activity in neural stem cells (NSCs) derived from induced pluripotent stem cells (iPSCs) of pediatric ADHD patients and showed that methylphenidate (MPH) and omega-3 polyunsaturated fatty acids (ω-3 PUFAs) can modulate this pathway. While MPH is a first-line treatment for ADHD, ω-3 PUFAs are under investigation as a potential non-pharmacological supplement. Using the same functionality-based reporter technology, we assessed Wnt activity in iPSC-derived NSCs from 5 adult ADHD patients and 5 healthy controls. We examined whether ω-3 fatty acids (EPA and DHA), alone or combined, and DHA with MPH can modulate Wnt activity in these NSCs. Basal Wnt responsiveness did not differ between adult ADHD and control lines, although genetic risk for ADHD was associated with increased Wnt activity. EPA showed no statistically significant effects, while DHA strongly increased Wnt activity in both groups. DHA combined with EPA increased Wnt activity in ADHD lines, whereas DHA with MPH caused group-specific responses: enhancing Wnt signaling in ADHD but reducing it in controls. Compared to NSCs derived from children, adult-derived NSCs behave differently and show distinct responses to EPA and DHA, suggesting a potential route toward refined therapeutic strategies for adults.Keywords: Attention-deficit/hyperactivity disorder, Neural stem cells, Wnt signaling, Omega-3, Docosahexaenoic acid, Methylphenidate Introduction Despite its neurodevelopmental nature, attention-deficit/hyperactivity disorder (ADHD) persists into adult life in around 60% of cases worldwide (Sibley et al., 2017). ADHD's multifactorial etiology, characterized by a complex interaction of genetic and environmental factors, remains unresolved, with heritability rates ranging from 77% to 88% (Faraone and Larsson, 2019). The psychostimulant methylphenidate (MPH) is widely used as the first recommendation in many guidelines for treating ADHD (Diagnosis and management guideline (NG87), 2019; AWMF, 2017). Its best-known mechanism of action involves blocking dopamine and norepinephrine transporters in presynaptic neurons (Kuczenski and Segal, 1997). Clinically, MPH leads to symptomatic improvements and has been linked to amelioration of structural and functional brain maturation delays observed in some patients (Castellanos et al., 2002; Frodl and Skokauskas, 2012; Hart et al., 2013; Nakao et al., 2011; Sobel et al., 2010; Shaw et al., 2009). However, approximately 30% of patients exhibit no or only partial response to MPH (Gajria et al., 2014; Quintero et al., 2010), and in adulthood, cardiovascular risks may restrict its use (Eroglu et al., 2023; Garcia-Argibay et al., 2024). It is therefore essential to explore novel therapeutic strategies, including non-pharmacological approaches such as omega-3 polyunsaturated fatty acids (ω-3 PUFAs). Interest in ω-3 as a potential anti-inflammatory therapeutic option for ADHD has increased in light of several promising findings. For instance, ω-3 deficiency has been suggested as a potential risk factor for ADHD (Richardson, 2006), and its supplementation has been shown to improve ADHD symptomatology in patients (Chang et al., 2018; Sonuga-Barke et al., 2013). Furthermore, the combination of MPH and ω-3 has been reported to show tolerability comparable to monotherapy with MPH, whilst also allowing a reduction in the MPH dose (Barragán et al., 2017). However, more research into this field is required. Both MPH and ω-3 PUFAs have been described as modulators of the canonical Wnt signaling pathway in neural cells (ShamsEldeen et al., 2021; Zhao et al., 2019; Grünblatt et al., 2018). Alongside other genetic and in vivo evidence, these findings suggest that the canonical Wnt signaling pathway is implicated in ADHD, as reviewed by our group in 2020 (Yde Ohki et al., 2020). Moreover, we recently reported disruptions in Wnt signaling in neural cell lines from children and adolescents diagnosed with ADHD, as well as modulatory effects of MPH and ω-3 (Walter et al., 2024, 2025). In induced pluripotent stem cell (iPSC)-derived neural stem cells (NSCs) from ADHD patients, our group previously demonstrated that Wnt activity is higher in ADHD NSCs derived from children and adolescents aged 6‒18 who respond clinically to MPH treatment (Walter et al., 2024). Furthermore, these NSCs exhibited impaired cell proliferation, a Wnt-modulated cellular process (Yde Ohki et al., 2023a, 2025). Earlier research from our group demonstrated that treatment with MPH at 10 nM and eicosapentaenoic acid (EPA) at 50 μM treatments can alter Wnt activity in NSCs from pediatric ADHD patients who show clinical response to MPH. In addition, the combination of docosahexaenoic acid (DHA) and MPH enhanced Wnt activity in both MPH responder and healthy control cell lines, while a 3:1 EPA:DHA ratio increased Wnt activity in NSCs from MPH non-responders (Walter et al., 2025). Taken together, these findings show that Wnt activity can be modulated in a group-specific manner. Alterations in this cellular pathway have also been described in other neurodevelopmental disorders (e.g. autism spectrum disorders and Pitt-Hopkins Syndrome), as demonstrated using iPSC-derived models (Papes et al., 2022; Marchetto et al., 2017; Sawada et al., 2020). These studies hypothesized that Wnt abnormalities may affect cellular phenotypes such as cell proliferation and ultimately have clinical implications. Concerning ADHD, Demontis et al. have recently reported Wnt-related rare genetic variants (i.e., in the LRP1 and WNT1 genes) associated with a higher risk of develop ADHD after analyzing the whole-exome genome-sequencing data from 8895 ADHD patients and 9001 controls (Demontis et al., 2025). To investigate whether adults with persistent ADHD exhibit alterations in Wnt activity comparable to those observed in pediatric ADHD patients, and consequently may benefit from PUFA treatment, we derived NSCs from adult ADHD patients and matched healthy controls. We examined whether treatments with MPH and ω-3 PUFA, specifically DHA and EPA, could modulate Wnt activity. In this context, a comprehensive understanding of the underlying molecular and cellular mechanisms, including Wnt signaling, may be crucial for elucidating ADHD pathophysiology and identifying novel therapeutic strategies. Methods Subject recruitment Adult ADHD patients (aADHD) and healthy controls (aControl) were recruited at the Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg (Germany), and the Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt (Germany). As described in McNeill et al. (2026), ADHD diagnoses were established independently by two psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), or Fifth Edition (DSM-5) criteria, supported by and self-report surveys tailored to ADHD, the Wender Utah Rating Scale – short form (WURS-k) (Retz-Junginger et al., 2002) and the ADHD Self-Report Scale (ADHS-SB) (Kessler et al., 2005). Healthy controls without any severe neurological, internal, infectious, or mental conditions were recruited and mental disorders were ruled out using the Mini-DIPS screening questionnaire (Margraf and Cwik, 2017). The study was approved by the Ethical Committees of the University of Würzburg (#96/11) and the University of Frankfurt (#425/14). All participants have provided signed informed consent forms. In this study, cell lines from 5 ADHD patients and 5